Aspire Biopharma Holdings, Inc. (ASBPW) Earnings History
Annual and quarterly earnings data from 2022 to 2024
Loading earnings history...
EPS Growth Rates (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
Download Data
Export ASBPW earnings history in CSV or JSON format
Free sign-in required to download data
Aspire Biopharma Holdings, Inc. (ASBPW) Earnings Overview
As of March 5, 2026, Aspire Biopharma Holdings, Inc. (ASBPW) reported trailing twelve-month net income of -$32M, reflecting -3.8% year-over-year growth. The company earned $-0.64 per diluted share over the past four quarters.
Looking at the long-term picture, ASBPW's historical earnings data spans multiple years. The company achieved its highest annual net income of $4M in fiscal 2023.
Aspire Biopharma Holdings, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to industry peers including CAI (-$538M net income, -0.7% margin), VCYT ($66M net income, 0.1% margin), ADPT (-$80M net income, -0.9% margin), ASBPW has comparable earnings metrics. Compare ASBPW vs CAI →
Peer Comparison
Earnings metrics vs industry competitors
Historical Data
3 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$13M | -380.8% | -$3M | $-1.52 | - | - |
| 2023 | $4M | +847.7% | -$1M | $0.54 | - | - |
| 2022 | $-597,000 | - | $-976,345 | $-0.07 | - | - |
See ASBPW's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ASBPW Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare ASBPW vs LLY
See how ASBPW stacks up against sector leader Eli Lilly and Company.
Start ComparisonFrequently Asked Questions
Is ASBPW growing earnings?
ASBPW EPS of $-0.64 reflects slowing growth at -3.8%, below the 5-year CAGR of N/A. TTM net income is $-32M. Expansion rate has moderated.
What are ASBPW's profit margins?
Aspire Biopharma Holdings, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are ASBPW's earnings?
ASBPW earnings data spans 2022-2024. The current earnings trend is -3.8% YoY. Historical data enables comparison across business cycles.